FSD Pharma Competitors

FSD Pharma (CNSX:HUGE) and Shopify (TSE:SHOP) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings for FSD Pharma and Shopify, as provided by MarketBeat.com.

Shopify has a consensus target price of C$1,835.00, indicating a potential upside of 21.25%.

Profitability

This table compares FSD Pharma and Shopify's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares FSD Pharma and Shopify's top-line revenue, earnings per share (EPS) and valuation.

Shopify has higher revenue and earnings than FSD Pharma.

Summary

Shopify beats FSD Pharma on 2 of the 2 factors compared between the two stocks.

FSD Pharma (CNSX:HUGE) and Constellation Software (TSE:CSU) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Profitability

This table compares FSD Pharma and Constellation Software's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and target prices for FSD Pharma and Constellation Software, as reported by MarketBeat.com.

Constellation Software has a consensus target price of C$1,754.86, suggesting a potential downside of 7.70%.

Earnings & Valuation

This table compares FSD Pharma and Constellation Software's top-line revenue, earnings per share and valuation.

Constellation Software has higher revenue and earnings than FSD Pharma.

Summary

Constellation Software beats FSD Pharma on 2 of the 2 factors compared between the two stocks.

Open Text (TSE:OTEX) and FSD Pharma (CNSX:HUGE) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Open Text and FSD Pharma, as provided by MarketBeat.

Open Text presently has a consensus target price of C$58.60, suggesting a potential downside of 5.61%.

Earnings and Valuation

This table compares Open Text and FSD Pharma's gross revenue, earnings per share (EPS) and valuation.

Open Text has higher revenue and earnings than FSD Pharma.

Profitability

This table compares Open Text and FSD Pharma's net margins, return on equity and return on assets.

Summary

Open Text beats FSD Pharma on 2 of the 2 factors compared between the two stocks.

FSD Pharma (CNSX:HUGE) and Lightspeed POS (TSE:LSPD) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings and valuation.

Profitability

This table compares FSD Pharma and Lightspeed POS's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings for FSD Pharma and Lightspeed POS, as provided by MarketBeat.

Lightspeed POS has a consensus price target of C$93.86, suggesting a potential upside of 11.27%.

Valuation & Earnings

This table compares FSD Pharma and Lightspeed POS's top-line revenue, earnings per share (EPS) and valuation.

FSD Pharma has higher earnings, but lower revenue than Lightspeed POS.

Summary

Lightspeed POS beats FSD Pharma on 2 of the 2 factors compared between the two stocks.

The Descartes Systems Group (TSE:DSG) and FSD Pharma (CNSX:HUGE) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation.

Valuation & Earnings

This table compares The Descartes Systems Group and FSD Pharma's gross revenue, earnings per share and valuation.

The Descartes Systems Group has higher revenue and earnings than FSD Pharma.

Profitability

This table compares The Descartes Systems Group and FSD Pharma's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and price targets for The Descartes Systems Group and FSD Pharma, as reported by MarketBeat.

The Descartes Systems Group presently has a consensus price target of C$64.25, indicating a potential downside of 21.99%.

Summary

The Descartes Systems Group beats FSD Pharma on 2 of the 2 factors compared between the two stocks.

Kinaxis (TSE:KXS) and FSD Pharma (CNSX:HUGE) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations and profitability.

Earnings & Valuation

This table compares Kinaxis and FSD Pharma's revenue, earnings per share and valuation.

Kinaxis has higher revenue and earnings than FSD Pharma.

Analyst Ratings

This is a summary of recent recommendations for Kinaxis and FSD Pharma, as provided by MarketBeat.

Kinaxis currently has a consensus target price of C$199.00, suggesting a potential upside of 26.23%.

Profitability

This table compares Kinaxis and FSD Pharma's net margins, return on equity and return on assets.

Summary

Kinaxis beats FSD Pharma on 2 of the 2 factors compared between the two stocks.